Cytokinetics (CYTK) Market Cap 2004–2026

As of January 27, 2026, Cytokinetics had a market cap of $7.826 billion, which increased by 1.29% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Jan 27, 2026, 4:00 PM ET
Cytokinetics logo

Cytokinetics, Inc. (CYTK)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$7.826B ▲ 1.29%
Jan 1, 2026
$7.769B ▲ 0.73%
1 Year Ago
$5.757B ▲ 35.94%
All-Time High
$10.983B ▼ 28.74%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.


📈 Cytokinetics Market Cap History by Year and Month

Cytokinetics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$7.826B▲ 0.73%
$7.826B▲ 0.73%
2025$7.769B▲ 39.71%
2024$5.561B▼ 32.07%
2023$8.186B▲ 88.79%
2022$4.336B▲ 12.19%

All market cap values reflect closing prices for the period shown.


📊 Cytokinetics Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $11.84B
  2. $11.73B
  3. $11.36B
  4. $10.95B
  5. $10.92B
  6. $9.33B
  7. $8.26B
  8. $8.04B
  9. $7.87B
  10. $7.83B
  11. $7.74B
  12. $7.32B
  13. $7.12B
  14. $7.04B
  15. $6.06B
  16. $5.91B
  17. $5.19B
  18. $5.19B
  19. $5.17B
  20. $4.25B

Data reflect the most recent market capitalization values available.

💡 What Is Market Capitalization and How Do We Calculate It?

For Cytokinetics, Inc. (CYTK), market capitalization represents the total market value of the company’s publicly traded shares. It helps investors understand Cytokinetics’s size within the health care sector and compare it with other companies in the same industry.

In most cases, market capitalization is calculated by multiplying the current share price by the number of basic shares outstanding. Basic shares represent the actual number of common shares that currently exist, without including potential future shares from employee stock options, RSUs, warrants, or convertible securities. For example, if Cytokinetics had one million basic shares and each traded at $50, its market capitalization would be $50 million.

Formula:
Market Cap = Share Price × Shares Outstanding

The value of Cytokinetics’s market capitalization changes throughout the trading day because it mainly depends on the current share price. The number of shares outstanding typically remains stable unless the company issues new shares, buys back its own stock, or grants stock options to employees.

Based on the latest data, Cytokinetics had a market capitalization of $7.826 billion, placing it in the mid-cap category within the health care industry.

Disclaimer: Despite all efforts, there may still be minor inaccuracies present in the data.